Scott Barrett - 22 Mar 2022 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Scott Barrett
Issuer symbol
IMRX
Transactions as of
22 Mar 2022
Net transactions value
+$6,736
Form type
4
Filing time
22 Mar 2022, 18:49:51 UTC
Previous filing
14 Feb 2022
Next filing
17 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Purchase $6,736 +900 +14% $7.48 7,563 22 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades through a broker-dealer. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at each price.